Insider Buying: Xylem (NYSE:XYL) Director Buys 11,000 Shares of Stock

Xylem Inc. (NYSE:XYL) Director D Christian Koch bought 11,000 shares of Xylem stock in a transaction on Thursday, October 29th. The stock was acquired at an average price of $89.60 per share, for a total transaction of $985,600.00. Following the transaction, the director directly owned 12,247 shares of the company’s stock, valued at approximately $1,097,331.20. This trade represents a 882.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Xylem Trading Up 2.8%

NYSE:XYL traded up $2.51 during trading hours on Thursday, reaching $90.74. 4,918,256 shares of the stock were exchanged, compared to its average volume of 2,172,384. Xylem Inc. has a twelve month low of $87.40 and a twelve month high of $154.27. The company has a quick ratio of 1.24, a current ratio of 1.61 and a debt-to-equity ratio of 0.23. The business has a 50-day moving average of $105.98 and a two-hundred day moving average of $118.05. The company has a market capitalization of $21.19 billion, a price-to-earnings ratio of 21.61, a PEG ratio of 1.75 and a beta of 1.00.

Xylem (NYSE:XYL) last announced its earnings results on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share for the quarter, missing the consensus estimate of $1.45 by ($0.01). The business had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.28 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%. Xylem’s quarterly revenue was down 3.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.37 earnings per share. On average, equities analysts predict that Xylem Inc. will post 5.65 EPS for the current year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th were paid a $0.43 dividend. The ex-dividend date was Thursday, August 27th. This represents a $1.72 dividend on an annualized basis and a yield of 1.9%. Xylem’s payout ratio is currently 40.95%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on XYL shares. Citigroup lowered their price objective on shares of Xylem from $148.00 to $130.00 and set a “buy” rating on the stock in a research report on Wednesday. JPMorgan Chase & Co. lowered Xylem from an “overweight” rating to a “neutral” rating and dropped their price objective for the stock from $118.00 to $90.00 in a report on Wednesday. Mizuho set a $99.00 price objective on shares of Xylem in a research note on Wednesday. Robert W. Baird set a $123.00 price objective on Xylem in a research note on Wednesday. Finally, Weiss Ratings downgraded Xylem from a “hold (c)” rating to a “sell (d)” rating in a research note on Wednesday. Nine research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $121.31.

Hedge Funds Weigh In On Xylem

A number of large investors have recently modified their holdings of the company. Woodmont Investment Counsel LLC increased its holdings in Xylem by 5.7% in the 3rd quarter. Woodmont Investment Counsel LLC now owns 49,043 shares of the industrial products company’s stock valued at $4,967,000 after purchasing an additional 2,655 shares in the last quarter. Bank Julius Baer & Co. Ltd Zurich grew its holdings in Xylem by 9.5% during the 3rd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 116,885 shares of the industrial products company’s stock worth $11,834,000 after acquiring an additional 10,149 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its position in shares of Xylem by 0.6% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 538,198 shares of the industrial products company’s stock worth $54,503,000 after purchasing an additional 3,000 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Xylem in the 3rd quarter valued at approximately $6,299,000. Finally, SFE Investment Counsel boosted its holdings in shares of Xylem by 9.7% in the 3rd quarter. SFE Investment Counsel now owns 53,592 shares of the industrial products company’s stock valued at $5,427,000 after buying an additional 4,755 shares during the period. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Key Xylem News

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: RBC initiated coverage with a moderate buy rating and a $125 price target, implying substantial upside from recent levels. RBC also reaffirmed its buy rating, while Citigroup, BNP Paribas Exane, Stifel, and Oppenheimer maintained positive ratings despite lowering their targets. RBC Capital Reaffirms Buy Rating
• Positive Sentiment: Unusually heavy call-option activity suggests some traders are positioning for a rebound: 20,508 calls changed hands, about 771% above average volume.
• Positive Sentiment: Some analysts view the selloff as excessive relative to Xylem’s longer-term growth potential. The company’s planned divestitures and new three-segment structure could streamline operations and sharpen its strategic focus.
• Neutral Sentiment: Analyst opinion is mixed. UBS lowered its price target to $99 and assigned a neutral rating, while Stifel reduced its target to $114 but retained a buy rating. The target reductions indicate more cautious near-term expectations even though most targets remain above the current share price.
• Negative Sentiment: Xylem’s third-quarter revenue of $2.20 billion missed the $2.28 billion consensus estimate, while adjusted EPS of $1.44 was slightly below expectations. Revenue declined 3% year over year, reinforcing concerns about slowing demand. Xylem Stock Price Sinks After Q3 Results
• Negative Sentiment: Management cut its 2026 outlook, a key reason for the post-earnings decline. JPMorgan downgraded the stock to underweight and lowered its target to $90, while elevated put-option activity points to continued downside hedging. Xylem Cuts 2026 Outlook
• Negative Sentiment: A law firm announced an investigation into potential securities-law violations related to the earnings shortfall, adding a further reputational and legal risk for shareholders. Xylem Investigation Notice

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.